• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌损伤可预测COVID-19患者短期全因死亡风险:一项剂量反应荟萃分析

Myocardial Injury Predicts Risk of Short-Term All-Cause Mortality in Patients With COVID-19: A Dose-Response Meta-Analysis.

作者信息

Li Yuehua, Pei Hanjun, Zhou Chenghui, Lou Ying

机构信息

Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Cardiology, The First Affiliated Hospital of Baotou Medical College, Baotou, China.

出版信息

Front Cardiovasc Med. 2022 May 2;9:850447. doi: 10.3389/fcvm.2022.850447. eCollection 2022.

DOI:10.3389/fcvm.2022.850447
PMID:35586652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9108210/
Abstract

OBJECTIVE

Predictive value of myocardial injury as defined by elevated cardiac tropnins (cTns) in patients with COVID-19 has not been fully investigated. We performed a meta-analysis to evaluate the dose-response relationship between myocardial injury and short-term all-cause mortality.

METHODS

Pubmed, Embase, and the Cochrane Library database were searched for all the studies which evaluated the relationship between cTns and the risk of short-term all-cause mortality in patients with COVID-19.

RESULTS

Compared with patients without myocardial injury, the group with elevated cTns was associated with increased short-term mortality (11 studies, 29,128 subjects, OR 3.17, 95% CI 2.19-4.59, = 0.000, = 92.4%, for heterogeneity 0.00). For the dose-response analysis, the elevation of cTns 1 × 99th percentile upper reference limit (URL) was associated with increased short-term mortality (OR 1.99, 95% CI 1.53-2.58, = 0.000). The pooled OR of short-term mortality for each 1 × URL increment of cTns was 1.25 (95% CI 1.22-1.28, = 0.000).

CONCLUSION

We found a positive dose-response relationship between myocardial injury and the risk of short-term all-cause mortality, and propose elevation of cTns > 1 × 99th percentile URL was associated with the increased short-term risk of mortality.

摘要

目的

新冠病毒病(COVID-19)患者中,心肌肌钙蛋白(cTn)升高所定义的心肌损伤的预测价值尚未得到充分研究。我们进行了一项荟萃分析,以评估心肌损伤与短期全因死亡率之间的剂量反应关系。

方法

检索了PubMed、Embase和Cochrane图书馆数据库,查找所有评估cTn与COVID-19患者短期全因死亡风险之间关系的研究。

结果

与无心肌损伤的患者相比,cTn升高的组短期死亡率增加(11项研究,29128名受试者,OR 3.17,95%CI 2.19 - 4.59,P = 0.000,I² = 92.4%,异质性P = 0.00)。对于剂量反应分析,cTn升高至第99百分位数上限参考值(URL)的1倍与短期死亡率增加相关(OR 1.99,95%CI 1.53 - 2.58,P = 0.000)。cTn每增加1倍URL,短期死亡率的合并OR为1.25(95%CI 1.22 - 1.28,P = 0.000)。

结论

我们发现心肌损伤与短期全因死亡风险之间存在正性剂量反应关系,并提出cTn升高>第99百分位数URL与短期死亡风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b0/9108210/5ad8c20fd7a3/fcvm-09-850447-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b0/9108210/d1e3b596368f/fcvm-09-850447-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b0/9108210/adf74498cea5/fcvm-09-850447-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b0/9108210/5ad8c20fd7a3/fcvm-09-850447-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b0/9108210/d1e3b596368f/fcvm-09-850447-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b0/9108210/adf74498cea5/fcvm-09-850447-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b0/9108210/5ad8c20fd7a3/fcvm-09-850447-g0003.jpg

相似文献

1
Myocardial Injury Predicts Risk of Short-Term All-Cause Mortality in Patients With COVID-19: A Dose-Response Meta-Analysis.心肌损伤可预测COVID-19患者短期全因死亡风险:一项剂量反应荟萃分析
Front Cardiovasc Med. 2022 May 2;9:850447. doi: 10.3389/fcvm.2022.850447. eCollection 2022.
2
Postoperative elevated cardiac troponin levels predict all-cause mortality and major adverse cardiovascular events following noncardiac surgery: A dose-response meta-analysis of prospective studies.术后升高的心肌肌钙蛋白水平可预测非心脏手术后的全因死亡率和主要不良心血管事件:前瞻性研究的剂量反应荟萃分析。
J Clin Anesth. 2023 Nov;90:111229. doi: 10.1016/j.jclinane.2023.111229. Epub 2023 Aug 11.
3
Periprocedural elevated myocardial biomarkers and clinical outcomes following elective percutaneous coronary intervention: a comprehensive dose-response meta-analysis of 44,972 patients from 24 prospective studies.择期经皮冠状动脉介入治疗后围手术期心肌生物标志物升高与临床结局:来自 24 项前瞻性研究的 44972 例患者的综合剂量反应荟萃分析。
EuroIntervention. 2020 Mar 20;15(16):1444-1450. doi: 10.4244/EIJ-D-19-00737.
4
Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression.肌钙蛋白在新型冠状病毒肺炎中的预后价值:一项诊断性荟萃分析和荟萃回归分析
Int J Infect Dis. 2021 Apr;105:312-318. doi: 10.1016/j.ijid.2021.02.113. Epub 2021 Mar 2.
5
Cardiac troponins predict adverse clinical outcomes in stable coronary artery disease: a dose-response meta-analysis of prospective studies.心肌肌钙蛋白可预测稳定性冠状动脉疾病的不良临床结局:前瞻性研究的剂量反应荟萃分析。
Biomarkers. 2019 Sep;24(6):556-565. doi: 10.1080/1354750X.2019.1606277. Epub 2019 May 31.
6
High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.高敏心肌肌钙蛋白检测:从改善分析性能到提高风险分层。
Crit Rev Clin Lab Sci. 2017 May;54(3):143-172. doi: 10.1080/10408363.2017.1285268. Epub 2017 May 1.
7
Diagnostic and prognostic value of minor elevated cardiac troponin levels for percutaneous coronary intervention-related myocardial injury: a prospective, single-center and double-blind study.轻度升高的心肌肌钙蛋白水平对经皮冠状动脉介入治疗相关心肌损伤的诊断和预后价值:一项前瞻性、单中心、双盲研究。
J Biomed Res. 2014 Mar;28(2):98-107. doi: 10.7555/JBR.28.20130124. Epub 2014 Feb 10.
8
Optimal Detection of Acute Myocardial Injury and Infarction with Cardiac Troponin: Beyond the 99th Percentile, into the High-Sensitivity Era.心脏肌钙蛋白检测急性心肌损伤和梗死的最佳方法:超越第 99 百分位,进入高敏时代。
Curr Cardiol Rep. 2020 Aug 4;22(9):101. doi: 10.1007/s11886-020-01350-w.
9
Prognostic performance of preoperative cardiac troponin and perioperative changes in cardiac troponin for the prediction of major adverse cardiac events and mortality in noncardiac surgery: A systematic review and meta-analysis.术前心肌肌钙蛋白和围手术期心肌肌钙蛋白变化对非心脏手术患者主要不良心脏事件和死亡率预测的预后性能:系统评价和荟萃分析。
PLoS One. 2019 Apr 22;14(4):e0215094. doi: 10.1371/journal.pone.0215094. eCollection 2019.
10
Acute cardiac injury in patients with COVID-19.新型冠状病毒肺炎患者的急性心脏损伤
Am J Cardiovasc Dis. 2020 Jun 15;10(2):28-33. eCollection 2020.

引用本文的文献

1
Myocardial injury and related mortality in hospitalized patients with COVID-19 during the Omicron pandemic: new perspectives and insights.奥密克戎流行期间住院 COVID-19 患者的心肌损伤和相关死亡率:新视角和见解。
Virol Sin. 2023 Dec;38(6):940-950. doi: 10.1016/j.virs.2023.10.005. Epub 2023 Oct 13.
2
Comparison of Incidence and Prognosis of Myocardial Injury in Patients with COVID-19-Related Respiratory Failure and Other Pulmonary Infections: A Contemporary Cohort Study.新型冠状病毒肺炎相关呼吸衰竭患者与其他肺部感染患者心肌损伤的发病率及预后比较:一项当代队列研究
J Clin Med. 2023 Oct 8;12(19):6403. doi: 10.3390/jcm12196403.
3

本文引用的文献

1
The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients.心脏肌钙蛋白对 COVID-19 患者 60 天死亡率和主要不良事件的预后价值。
Cardiovasc Pathol. 2021 Nov-Dec;55:107374. doi: 10.1016/j.carpath.2021.107374. Epub 2021 Aug 3.
2
Association of Cardiac Troponin T Concentration on Admission with Prognosis in Critically Ill Patients without Myocardial Infarction: A Cohort Study.入院时心肌肌钙蛋白T浓度与无心肌梗死危重症患者预后的关联:一项队列研究
Int J Gen Med. 2021 Jun 22;14:2729-2739. doi: 10.2147/IJGM.S318232. eCollection 2021.
3
The prognostic role of cardiac troponin in hospitalized COVID-19 patients.
Impact of concomitant COVID-19 on the outcome of patients with acute myocardial infarction undergoing coronary artery angiography.
新型冠状病毒肺炎(COVID-19)合并感染对接受冠状动脉造影的急性心肌梗死患者预后的影响。
Front Cardiovasc Med. 2022 Sep 22;9:917250. doi: 10.3389/fcvm.2022.917250. eCollection 2022.
4
Myocardial Injuries in COVID-19: More Questions Than Answers.新型冠状病毒肺炎中的心肌损伤:问题多于答案
J Clin Med. 2022 Aug 3;11(15):4527. doi: 10.3390/jcm11154527.
心脏肌钙蛋白在住院 COVID-19 患者中的预后作用。
Atherosclerosis. 2021 May;325:83-88. doi: 10.1016/j.atherosclerosis.2021.04.006. Epub 2021 Apr 17.
4
Electrocardiographic Risk Stratification in COVID-19 Patients.新型冠状病毒肺炎患者的心电图风险分层
Front Cardiovasc Med. 2021 Feb 2;8:636073. doi: 10.3389/fcvm.2021.636073. eCollection 2021.
5
Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome.严重 COVID-19 与非 COVID-19 急性呼吸窘迫综合征的心肌损伤比较。
Circulation. 2021 Feb 9;143(6):553-565. doi: 10.1161/CIRCULATIONAHA.120.050543. Epub 2020 Nov 13.
6
Myocardial Injury in Adults Hospitalized With COVID-19.新冠病毒肺炎住院成人患者的心肌损伤
Circulation. 2020 Dec 15;142(24):2393-2395. doi: 10.1161/CIRCULATIONAHA.120.050434. Epub 2020 Nov 5.
7
Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19.因 COVID-19 住院患者肌钙蛋白 T 和 B 型利钠肽的预后价值。
Arq Bras Cardiol. 2020 Oct;115(4):660-666. doi: 10.36660/abc.20200385.
8
Usefulness of Elevated Troponin to Predict Death in Patients With COVID-19 and Myocardial Injury.肌钙蛋白升高对 COVID-19 合并心肌损伤患者死亡的预测价值。
Am J Cardiol. 2021 Jan 1;138:100-106. doi: 10.1016/j.amjcard.2020.09.060. Epub 2020 Oct 13.
9
Association between cardiac troponin I and mortality in patients with COVID-19.新型冠状病毒肺炎患者心肌肌钙蛋白 I 与死亡率的关系。
Biomarkers. 2020 Dec;25(8):634-640. doi: 10.1080/1354750X.2020.1831609. Epub 2020 Nov 24.
10
Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19.COVID-19 患者入院后的心脏损伤模式和住院结局。
Am J Cardiol. 2020 Oct 15;133:154-161. doi: 10.1016/j.amjcard.2020.07.040. Epub 2020 Jul 24.